Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development
Céline Dutruel(German Cancer Research Center), Peter Schmezer(German Cancer Research Center), Christoph Plass(German Cancer Research Center), P. Sivaramakrishna Rachakonda(German Cancer Research Center), Thomas M. Kaffenberger(German Cancer Research Center), Ilse Rooman(Vrije Universiteit Brussel), Michael Rehli(University Hospital Regensburg), Dieter Weichenhan(University of Lübeck), Huaping Xie(Tongji Hospital), Manuela Zucknick(German Cancer Research Center), Peter Schirmacher(Memorial Sloan Kettering Cancer Center), Andrea S. Bauer(Hammersmith Hospital), Changki Hong(UCSF Helen Diller Family Comprehensive Cancer Center), Odilia Popanda(German Cancer Research Center), J Costello(University of California, San Francisco), Rajiv Kumar(German Cancer Research Center), Julia Werner(Heidelberg University), N. Giese(Heidelberg University), Lea Geiselhart(German Cancer Research Center), Frank Bergmann(Heidelberg University), Jörg D. Hoheisel(Heidelberg University)
Cited by 38
Related Papers
The NIH Roadmap Epigenomics Mapping Consortium
|Nature Biotechnology|2010|2k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Complete genome sequence and comparative analysis of the metabolically versatile <i>Pseudomonas putida</i> KT2440
|Environmental Microbiology|2002|1.4k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k